73 results
Page 2 of 4
8-K
EX-1.1
3thi7mg1y6lruzu8
31 May 23
TScan Therapeutics Announces Launch of Proposed Public Offering
8:16am
424B5
tfu86v 6l
26 May 23
Prospectus supplement for primary offering
8:12pm
424B5
87lv7t
25 May 23
Prospectus supplement for primary offering
4:59pm
8-K
EX-1.1
yi7w223l7k50zuag
16 May 23
Other Events
5:21pm
424B5
p89cbe6
16 May 23
Prospectus supplement for primary offering
5:19pm
8-K
EX-99.1
e1pljnv
9 May 23
Amgen and Tscan Therapeutics Announce Collaboration to Identify Novel Targets In Crohn’s Disease
9:15am
S-3
y1m12gcn3fkare0v
9 Nov 22
Shelf registration
7:53am
S-3
EX-4.4
8yzs6n7
9 Nov 22
Shelf registration
7:53am
S-3
EX-4.5
e13eein
9 Nov 22
Shelf registration
7:53am
8-K
EX-10.1
h8zcc581yzng
12 Sep 22
TScan Therapeutics Secures Convertible Debt Facility for up to $60 Million with K2 HealthVentures
7:51am
DEF 14A
a2ojobuse vgq
21 Apr 22
Definitive proxy
8:00am
10-K
25tu1p4j7bi7itg
9 Mar 22
Annual report
7:30am
8-K
EX-10.1
htkqxet3iepaau9j5egw
2 Dec 21
Entry into a Material Definitive Agreement
7:31am